YDES Stock YD Bio (YDES, $2.98) gained +31.28% in one month, becoming one of the top market winners among penny stocks
at Tickeron.com
Loading...
A.I.dvisor analyzed 595 other stocks in the Biotechnology Industry for the month ending August 14, 2026, and discovered that of them (4) exhibited an Uptrend while of them (5) exhibited a Downtrend.
YDES in upward trend: 10-day moving average moved above 50-day moving average on August 14, 2026
The 10-day moving average for YDES crossed bullishly above the 50-day moving average on August 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 4 of 9 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 44%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on September 11, 2026. You may want to consider a long position or call options on YDES as a result. In 37 of 109 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 34%.
YDES moved above its 50-day moving average on August 11, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where YDES advanced for three days, in 40 of 122 cases, the price rose further within the following month. The odds of a continued upward trend are 33%.
The Aroon Indicator entered an Uptrend today. In 79 of 246 cases where YDES Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 32%.
Bearish Trend Analysis
The 10-day RSI Indicator for YDES moved out of overbought territory on August 31, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In 2 of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at 6%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 14 of 57 cases where YDES's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 25%.
The Moving Average Convergence Divergence Histogram (MACD) for YDES turned negative on September 01, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 60 similar instances when the indicator turned negative. In 18 of the 60 cases the stock turned lower in the days that followed. This puts the odds of success at 30%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where YDES declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 48%.
YDES broke above its upper Bollinger Band on August 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 38 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. YDES’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 80 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 100 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (61.350) is normal, around the industry mean (19.994). YDES's P/E Ratio (898.981) is considerably higher than the industry average of (27.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.527). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (222.222) is also within normal values, averaging (427.627).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. YDES’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.